Discovering a new drug is only the beginning: progress and challenges in expanding access to BDQ for MDR-TB treatment

Int J Tuberc Lung Dis. 2020 Oct 1;24(10):985-986. doi: 10.5588/ijtld.20.0562.

¹ Institute of Infectious Disease and Molecular Medicine and Wellcome Centre for Infectious Disease Research, University of Cape Town, Cape Town, South Africa.
² Rollins School of Public Health and School of Medicine, Emory University, Atlanta, GA.
³ Rollins School of Public Health and School of Medicine, Emory University, Atlanta, GA, Bureau for Global Health, US Agency for International Development, Washington, DC, USA, <email></email>, Email: [email protected].

No abstract available

Publication types